UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2758-2765

2009

Volltextzugriff (PDF)

Radiation Therapy for Early-Stage Breast Cancer after Breast-Conserving Surgery

The New England journal of medicine, 2009-01, Vol.360 (1), p.63-70

Buchholz, Thomas A

2009

Volltextzugriff (PDF)

Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4222-4228

2013

Volltextzugriff (PDF)

Improved survival using intensity‐modulated radiation therapy in head and neck cancers: A SEER‐Medicare analysis

Cancer, 2014-03, Vol.120 (5), p.702-710

2014

Volltextzugriff (PDF)

Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2007-2014

2009

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3784-3796

2010

Volltextzugriff (PDF)

Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer

Journal of clinical oncology, 2014-07, Vol.32 (19), p.2010-2017

2014

Volltextzugriff (PDF)

Use of Radiation Therapy in the Last 30 Days of Life Among a Large Population-Based Cohort of Elderly Patients in the United States

Journal of clinical oncology, 2013-01, Vol.31 (1), p.80-87

2013

Volltextzugriff (PDF)

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

Journal of clinical oncology, 2009-12, Vol.27 (34), p.5700-5706

2009

Volltextzugriff (PDF)

Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?

Journal of clinical oncology, 2011-12, Vol.29 (35), p.4647-4653

2011

Volltextzugriff (PDF)

Hazard of Recurrence among Women after Primary Breast Cancer Treatment—A 10-Year Follow-up Using Data from SEER-Medicare

Cancer epidemiology, biomarkers & prevention, 2012-05, Vol.21 (5), p.800-809

2012

Volltextzugriff (PDF)

The Future of Radiation Oncology in the United States From 2010 to 2020: Will Supply Keep Pace With Demand?

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5160-5165

2010

Volltextzugriff (PDF)

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer

Journal of clinical oncology, 2011-07, Vol.29 (19), p.2628-2634

2011

Volltextzugriff (PDF)

Nomogram to Predict the Benefit of Radiation for Older Patients With Breast Cancer Treated With Conservative Surgery

Journal of clinical oncology, 2012-08, Vol.30 (23), p.2837-2843

2012

Volltextzugriff (PDF)

Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy

Journal of clinical oncology, 2011-05, Vol.29 (15), p.1956-1962

2011

Volltextzugriff (PDF)

Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase III Clinical Trial

International journal of radiation oncology, biology, physics, 2012-07, Vol.83 (4), p.1089-1094

2012

Volltextzugriff (PDF)

Increasing the value of radiotherapy in breast cancer

The lancet oncology, 2021-05, Vol.22 (5), p.572-573

Buchholz, Thomas A

2021

Volltextzugriff (PDF)

Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients After Radiotherapy

Journal of clinical oncology, 2008-11, Vol.26 (31), p.5119-5125

2008

Volltextzugriff (PDF)

Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current American Joint Committee on Cancer Staging System

Journal of clinical oncology, 2011-12, Vol.29 (35), p.4654-4661

2011

Volltextzugriff (PDF)

Microtubule-Associated Protein Tau: A Marker of Paclitaxel Sensitivity in Breast Cancer

Proceedings of the National Academy of Sciences - PNAS, 2005-06, Vol.102 (23), p.8315-8320

2005

Volltextzugriff (PDF)

Combined Use of Clinical and Pathologic Staging Variables to Define Outcomes for Breast Cancer Patients Treated With Neoadjuvant Therapy

Journal of clinical oncology, 2008-01, Vol.26 (2), p.246-252

2008

Volltextzugriff (PDF)

Local-Regional Recurrence With and Without Radiation Therapy After Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3N0 Breast Cancer

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.782-787

2011

Volltextzugriff (PDF)

Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells

Breast cancer research and treatment, 2012-07, Vol.134 (2), p.495-510

2012

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(168)

Publikationsform

Artikel
(182)
Bücher
(1)

Sprache

Englisch
(183)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

Radiation Therapy for Early-Stage Breast Cancer after Breast-Conserving Surgery

Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer

Improved survival using intensity‐modulated radiation therapy in head and neck cancers: A SEER‐Medicare analysis

Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer

Use of Radiation Therapy in the Last 30 Days of Life Among a Large Population-Based Cohort of Elderly Patients in the United States

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Hazard of Recurrence among Women after Primary Breast Cancer Treatment—A 10-Year Follow-up Using Data from SEER-Medicare

The Future of Radiation Oncology in the United States From 2010 to 2020: Will Supply Keep Pace With Demand?

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer

Nomogram to Predict the Benefit of Radiation for Older Patients With Breast Cancer Treated With Conservative Surgery

Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy

Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase III Clinical Trial

Increasing the value of radiotherapy in breast cancer

Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients After Radiotherapy

Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current American Joint Committee on Cancer Staging System

Microtubule-Associated Protein Tau: A Marker of Paclitaxel Sensitivity in Breast Cancer

Combined Use of Clinical and Pathologic Staging Variables to Define Outcomes for Breast Cancer Patients Treated With Neoadjuvant Therapy

Local-Regional Recurrence With and Without Radiation Therapy After Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3N0 Breast Cancer

Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells

Aktive Filter

Suchergebnisse filtern